Briton Froome cleared by UCI in doping case
Print Edition
Four-time Tour de France winner Chris Froome was cleared by cycling鈥檚 world governing body yesterday of any wrongdoing after he tested positive for excessive levels of the asthma drug salbutamol and he is free to race in this year鈥檚 event, starting on Saturday.
Froome, 33, had tested positive for excessive levels of salbutamol following a urine sample at last September鈥檚 Vuelta a Espana.
鈥淥n 28 June 2018, World Anti-Doping Agency (WADA) informed the UCI that it would accept, based on the specific facts of the case, that Mr Froome鈥檚 sample results do not constitute an Adverse Analytical Finding,鈥 the International Cycling Union, or UCI, said in a statement. 鈥淚n light of WADA鈥檚 unparalleled access to information and authorship of the salbutamol regime, the UCI has decided, based on WADA鈥檚 position, to close the proceedings against Mr Froome.鈥
The Briton had always denied any wrongdoing and has now been cleared to race in this year鈥檚 Tour de France by the organizers who had attempted to prevent the rider from competing while under investigation.
鈥淲e started a procedure three weeks ago claiming that Chris Froome taking part in the Tour de France would damage the reputation of the race. But now that the UCI has cleared him there鈥檚 no reason for us to prevent him from participating in the race,鈥 Tour de France director Christian Prudhomme said.
Froome welcomed the news which means he can attempt to win a record-equalling fifth Tour when the race gets under way in Noirmoutier.
Team Sky鈥檚 Froome can match the record of five titles shared by Jacques Anquetil, Eddy Merckx, Bernard Hinault and Miguel Indurain.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
